IBSS BIOMED S.A. is expanding dynamically also in the field of research and development.

In collaboration with science and clinical centres, the company conducts research programs within the scope of its activity with the aim of developing new products. For subsequent research development programs interdisciplinary teams are organized.

At present, the company is focusing on designing and introducing new preparations. In order to meet market demands and quality norms, IBSS BIOMED S.A. constantly improves already existing original products (probiotics, vaccines, allergens), implements new technologies as well as research methods, and perfects the functioning and equipment of its laboratories. Within the framework of R&D project teams and clinical trials, the company cooperates with independent consultants.

Clinical research of already existing or new products complies with the best international standards. They are conducted in line with the ethical principles stated in Declaration of Helsinki, and the principles of Good Clinical Practice.

The company guarnatees that due to the application of GMP System (Good Manufacturing Practice), IBSS BIOMED products fully comply with quality and safety norms.